Medical Culture Medium Manufacturing (Motility Testing)

The contract requires the manufacture and supply of sterile culture medium specifically formulated for motility determination in clinical or military medical testing environments. The product must adhere to current good manufacturing practices (cGMP) and maintain a minimum shelf life of 12 months to ensure reliability and safety in critical diagnostic applications. The medium is intended for use in high-stakes medical scenarios where accurate motility assessment is essential for pathogen identification and treatment decisions. Manufacturing must be performed to strict quality control standards to guarantee batch consistency, sterility, and performance under field and laboratory conditions. The contract is classified as a subcontract under the NAICS code 325414, associated with pharmaceutical and medicine manufacturing, and is managed by the Department of Defense through the Medical Supply Chain MD Surg FSF. The place of performance is designated as Williamsburg, Virginia, with a ZIP code of 23185-5830, indicating localized coordination for delivery and potential oversight. Solicitations closed on August 10, 2026, with the requirement posted on August 2, 2026, suggesting a tight turnaround for qualified manufacturers to respond. While no set-aside or specific organization type is indicated, compliance with defense supply chain protocols and cGMP remains non-negotiable for contractor eligibility.